Darbufelone
CAS No. 139226-28-1
Darbufelone( CI-1004 )
Catalog No. M26144 CAS No. 139226-28-1
Darbufelone is a dual inhibitor of cellular PGF2α and LTB4 production.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 120 | Get Quote |
|
10MG | 201 | Get Quote |
|
25MG | 441 | Get Quote |
|
50MG | 644 | Get Quote |
|
100MG | 888 | Get Quote |
|
500MG | 1782 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDarbufelone
-
NoteResearch use only, not for human use.
-
Brief DescriptionDarbufelone is a dual inhibitor of cellular PGF2α and LTB4 production.
-
DescriptionDarbufelone is a dual inhibitor of cellular PGF2α and LTB4 production. Darbufelone potently inhibits PGHS-2 (IC50= 0.19 μM) but is much less potent with PGHS-1 (IC50=20 μM).(In Vitro):Darbufelone (5 - 60 μM) increases the cell growth inhibitory effects in A549, H520 and H460 cell lines with IC50s of 20, 21 and 15 μM.(In Vivo):Darbufelone (80 mg/kg/day) decreases the tumor volumes in a time-dependent manner. Darbufelone (20 or 40 mg/kg/day) dos not show any significant inhibition of tumor weight. At necropsy, Darbufelone (80 mg/kg/day) reduces the tumor weight by 30.2%.
-
In VitroDarbufelone is a noncompetitive inhibitor of PGHS-2 (Ki=10±5 μM). Darbufelone quenches the fluorescence of PGHS-2 at 325 nm (lambda(ex)=280 nm) with Kd=0.98±0.03 μM.To test the putative anti-proliferative effect of Darbufelone, A549, H520 and H460 cell lines are used, which are established from three distinct pathological subtypes of NSCLC (adenocarcinoma, squamous and large cell lung cancer respectively). Increasing concentrations of Darbufelone, ranging from 5 to 60 μM, are tested for 72 h. The cell growth inhibition of these three cell lines gradually increases with higher drug concentration. The IC50 of A549 and H520 are 20±3.6 and 21±1.8 μM, respectively, while the H460 has much lower IC50 (15±2.7 μM).
-
In VivoDarbufelone is a dual inhibitor of cellular PGF2R and LTB4 production. Darbufelone is orally active and nonulcerogenic in animal models of inflammation and arthritis. When mice are treated with Darbufelone at dosage of 80 mg/kg/day, the tumor volumes decrease in a time-dependent manner. In contrast, lower dose of Darbufelone (20 or 40 mg/kg/day) dos not show any significant inhibition of tumor weight. At necropsy, the tumor weight in mice treated with Darbufelone (80 mg/kg/day) is reduced by 30.2% in comparison with control group.
-
SynonymsCI-1004
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number139226-28-1
-
Formula Weight332.46
-
Molecular FormulaC18H24N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)c1cc(\C=C2/SC(N)=NC2=O)cc(c1O)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Secoxyloganin
Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.
-
Dazoxiben
Dazoxiben is a potent inhibitor of thromboxane (TX) synthase.
-
E7046
E7046 is an orally bioavailable and specific EP4 antagonist, with IC50 of 13.5 nM and Ki of 23.14 nM. E7046 exhibits anti-tumor activities.